Journal of Viral Hepatitis

Aims & Scope

The Journal of Viral Hepatitis publishes reviews, original work (full papers) and short, rapid communications in the area of viral hepatitis.

It solicits these articles from epidemiologists, clinicians, pathologists, virologists and specialists in transfusion medicine working in the field, thereby bringing together in a single journal the important issues in this expanding speciality.

The Journal of Viral Hepatitis is a monthly journal, publishing reviews, original work (full papers) and short rapid communications in the area of viral hepatitis.

It brings together in a single journal important issues in this rapidly expanding speciality including articles from: virologists; epidemiologists; clinicians; pathologists; specialists in transfusion medicine.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.3
2024	2.50

SJR (SCImago Journal Rank)

Year	Value
2024	0.813

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	112

Journal Rank

Year	Value
2024	6633

Journal Citation Indicator

Year	Value
2024	1084

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Immunology and Microbiology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

  Citation: 1891

  Authors: D.

• Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies

  Citation: 663

  Authors: J. M., J. M., G. J.

• Global surveillance and control of hepatitis C

  Citation: 548

  Authors:

• Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases

  Citation: 516

  Authors: B., F., A. M., P., R., P., F., M. R.

• Peginterferon α‐2a (40 kDa): an advance in the treatment of hepatitis B e antigen‐positive chronic hepatitis B

  Citation: 362

  Authors: W. G. E., T., S.‐D., V., Y.‐C., T., A., W. Yu, F. E., N.

• Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta‐analysis

  Citation: 358

  Authors: M., J., M., I., C., D., H., M., T., S., E.

• Alanine aminotransferase‐based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B

  Citation: 334

  Authors: H. L.‐Y., G. L.‐H., P. C.‐L., A. W.‐H., A. M.‐L., K. K.‐L., F. K.‐L., J. J.‐Y., V. W.‐S.

• Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double‐blind, placebo‐controlled study

  Citation: 292

  Authors: W.‐M., Y.‐T., L., H., Z.‐Q., X.‐M., S.‐L., F.‐Y., F., C.‐N., S., M.

• The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

  Citation: 289

  Authors: H., I., C., R. P., R., F., W., M. C., C., P., U., S., Ä°., T., F., M., A. J., C. E., P., M., J. L., H., P. B., M., H. S. M., M. E., G. J., W., A. S., M. H., G., G., K., J., M. L. G., P. R., S., J., J., J. A., F. L., E., M., M., S. J., H., P., M., K. D. E., A., S., M., H., W., D., R. T., P., S., C., K., F., V., N., A. L. H., J., K., K. M., A., N., S. K., W. M., F., S. D., R., D., M., G. E., W., J., P., R. E., A. J., P., P., I., H., D., H., N., J., A., A., M., B., C.

• Virologic factors associated with failure to passive–active immunoprophylaxis in infants born to HBsAg‐positive mothers

  Citation: 288

  Authors: H., Y., Z., H., C.

---